In-depth study on the gene silencing capability of silica nanoparticles with different pore sizes: degree and duration of RNA interference

RSC Advances ◽  
2016 ◽  
Vol 6 (32) ◽  
pp. 27143-27150 ◽  
Author(s):  
Seongchan Kim ◽  
Hee-Kyung Na ◽  
Cheolhee Won ◽  
Dal-Hee Min

The mesoporous silica nanoparticles (MSN) having different pore sizes were synthesized and utilized for siRNA delivery system capable of controlling kinetics of RNA interference.

2015 ◽  
Vol 25 (18) ◽  
pp. 2646-2659 ◽  
Author(s):  
Worapol Ngamcherdtrakul ◽  
Jingga Morry ◽  
Shenda Gu ◽  
David J. Castro ◽  
Shaun M. Goodyear ◽  
...  

2018 ◽  
Vol 13 (6) ◽  
pp. 592-599 ◽  
Author(s):  
Anna Slita ◽  
Anna Egorova ◽  
Eudald Casals ◽  
Anton Kiselev ◽  
Jessica M. Rosenholm

RSC Advances ◽  
2018 ◽  
Vol 8 (43) ◽  
pp. 24633-24640 ◽  
Author(s):  
Jie Li ◽  
Suqin Shen ◽  
Fei Kong ◽  
Ting Jiang ◽  
Cui Tang ◽  
...  

MSN with suitable pore sizes achieved an outstanding performance for in vitro and in vivo antitumor efficacies.


Molecules ◽  
2020 ◽  
Vol 25 (3) ◽  
pp. 742 ◽  
Author(s):  
Thashini Moodley ◽  
Moganavelli Singh

The fruition, commercialisation and clinical application combining nano-engineering, nanomedicine and material science for utilisation in drug delivery is becoming a reality. The successful integration of nanomaterial in nanotherapeutics requires their critical development to ensure physiological and biological compatibility. Mesoporous silica nanoparticles (MSNs) are attractive nanocarriers due to their biodegradable, biocompatible, and relative malleable porous frameworks that can be functionalized for enhanced targeting and delivery in a variety of disease models. The optimal formulation of an MSN with polyethylene glycol (2% and 5%) and chitosan was undertaken, to produce sterically stabilized, hydrophilic MSNs, capable of efficient loading and delivery of the hydrophobic anti-neoplastic drug, doxorubicin (DOX). The pH-sensitive release kinetics of DOX, together with the anticancer, apoptosis and cell-cycle activities of DOX-loaded MSNs in selected cancer cell lines were evaluated. MSNs of 36–60 nm in size, with a pore diameter of 9.8 nm, and a cumulative surface area of 710.36 m2/g were produced. The 2% pegylated MSN formulation (PCMSN) had the highest DOX loading capacity (0.98 mgdox/mgmsn), and a sustained release profile over 72 h. Pegylated-drug nanoconjugates were effective at a concentration range between 20–50 μg/mL, inducing apoptosis in cancer cells, and affirming their potential as effective drug delivery vehicles.


2020 ◽  
Vol 8 (10) ◽  
pp. 2096-2106 ◽  
Author(s):  
Eun-Bi Lim ◽  
Tran Anh Vy ◽  
Sang-Wha Lee

Multifunctional mesoporous silica nanoparticles (MSNs) can confer dynamically varied release kinetics depending on the intermolecular interactions between model drugs and functional decorations on the MSNs.


Nanoscale ◽  
2017 ◽  
Vol 9 (16) ◽  
pp. 5329-5341 ◽  
Author(s):  
Jianliang Shen ◽  
Haoran Liu ◽  
Chaofeng Mu ◽  
Joy Wolfram ◽  
Wei Zhang ◽  
...  

2016 ◽  
Vol 79 (2) ◽  
pp. 319-327 ◽  
Author(s):  
Katharina Braun ◽  
Alexander Pochert ◽  
Michaela Beck ◽  
Richard Fiedler ◽  
Jens Gruber ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document